More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$13.53B
EPS
6.4
P/E ratio
20
Price to sales
1.96
Dividend yield
0.609%
Beta
0.847823
Previous close
$142.11
Today's open
$140.88
Day's range
$137.67 - $142
52 week range
$92.77 - $143.90
show more
CEO
Mark J. Tarr
Employees
42000
Headquarters
Birmingham, AL
Exchange
New York Stock Exchange
Shares outstanding
98123613
Issue type
Common Stock
Healthcare
Healthcare Providers & Services
Why Encompass Health (EHC) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks Investment Research • 5 hours ago

Encompass Health Stock Rallies 34% YTD: Is There More Upside Ahead?
Encompass Health Corporation EHC has soared 33.9% year to date, edging past the industry's 32% gain and comfortably beating the S&P 500's 9.4% rise. Consistent operating growth, improving profitability outlook, strategic capacity expansion and shareholder-friendly initiatives have helped keep buyers interested.
Zacks Investment Research • Nov 17, 2026

TimesSquare Global Concentrated Small Cap Q3 2026 Portfolio Activity
During this quarter, the Global Concentrated Small Cap strategy underperformed the MSCI World Small Cap Index. Encompass Health's shares rose after the company's results exceeded expectations, with discharge volumes growing faster than anticipated, and management raised its full-year revenue, profit and earnings guidance for the second consecutive quarter. Despite recent results exceeding expectations and MYR Group posting record revenue and backlog, shares fell over the course of the quarter on fears of growing political opposition to data center construction across the U.S.
Seeking Alpha • Nov 17, 2026

Encompass Health (EHC) is a Top-Ranked Momentum Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks Investment Research • Nov 12, 2026

Should Value Investors Buy Encompass Health (EHC) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks Investment Research • Nov 9, 2026

Encompass Health announces indefinite closure of Sea Pines Rehabilitation Hospital due to flood damage
BIRMINGHAM, Ala., and MELBOURNE, Fla.
PRNewsWire • Nov 6, 2026

Encompass Health Corporation (EHC) Hits Fresh High: Is There Still Room to Run?
Encompass Health (EHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks Investment Research • Nov 2, 2026

Encompass Health (EHC) Is Up 9.52% in One Week: What You Should Know
Does Encompass Health (EHC) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks Investment Research • Nov 2, 2026

Encompass Health Q3 Earnings Call Highlights
Encompass Health NYSE: EHC raised its full-year 2026 outlook after reporting third-quarter revenue growth of 8.9%, adjusted EBITDA growth of 15.5% and adjusted earnings-per-share growth of 23.6%, driven by higher discharges, increased patient acuity and revenue per discharge.
MarketBeat • Oct 30, 2026

Here's Why Encompass Health (EHC) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Investment Research • Oct 30, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Encompass Health Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.